de Armas-Rillo, Laura
Quevedo-Abeledo, Juan Carlos
Hernández-Hernández, Vanesa
de Vera-González, Antonia
González-Delgado, Alejandra
García-Dopico, José A.
González-Gay, Miguel Á.
Ferraz-Amaro, Iván http://orcid.org/0000-0003-0197-5267
Funding for this research was provided by:
instituto de salud carlos iii (PI17/00083)
Article History
Received: 19 July 2021
Accepted: 19 April 2022
First Online: 29 April 2022
Declarations
:
: The study protocol was approved by the institutional review committees at Hospital Universitario de Canarias and Hospital Universitario Doctor Negrín, and all subjects provided written informed consent.
: Not applicable.
: The authors declare that they have no competing interests. Nevertheless, Professor MA Gonzalez-Gay and Dr. Iván Ferraz-Amaro would like to acknowledge that they received grants/research supports from Abbott, MSD, Jansen, and Roche and received consultation fees from company-sponsored speakers bureaus associated with Abbott, Pfizer, Roche, Sanofi, Sobi, Amgen, Celgene, and MSD.